

Alenka Brzulja
Vice President of Cardiovascular & Specialty Solutions EMEA, Johnson & Johnson Medical Devices CompaniesVice President of Cardiovascular & Specialty Solutions EMEA, Johnson & Johnson Medical Devices Companies. Alenka joined Johnson & Johnson more than 20 years ago and has held several roles of increasing local and regional responsibility across Johnson & Johnson sectors. A MedTech enthusiast who continues to challenge what’s possible in healthcare, towards ensuring that each patient can access the technology and solutions that can make a meaningful difference to their health, every day.
In her current role, Alenka leads Biosense Webster, Cerenovus and Mentor companies which develop innovative technologies in the field of cardiac arrhythmias treatment, ischemic and hemorrhagic stroke treatment and breast surgery.
Alenka holds an Economics degree from the University of Ljubljana and obtained her MBA from Hofstra University in New York. She resides in Slovenia with her family.
Posted on 13.10.2021
How innovation is transforming stroke care?


By Alenka Brzulja, Vice President of Cardiovascular & Specialty Solutions EMEA, Johnson & Johnson Medical Devices Companies
Posted on 05.06.2020
How a focus on efficiency can help treat more atrial fibrillation patients


By Alenka Brzulja, Vice President of Cardiovascular & Specialty Solutions EMEA, Johnson & Johnson Medical Devices Companies
Posted on 05.12.2019
Millions of patients suffering with AF may be missing out on a life-saving procedure


By Alenka Brzulja, Vice President of Cardiovascular & Specialty Solutions EMEA, Johnson & Johnson Medical Devices Companies